Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 14 of 40 found articles
 
 
  Correction to: The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab
 
 
Title: Correction to: The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab
Author: Tanaka, Kazuki
Adams, Brigitte
Aris, Alvaro Madrid
Fujita, Naoya
Ogawa, Masayo
Ortiz, Stephan
Vallee, Marc
Greenbaum, Larry A.
Appeared in: Pediatric nephrology
Paging: Volume 36 () nr. 4 pages 1033
Year: 2020-12-09
Contents:
Publisher: Springer Berlin Heidelberg, Berlin/Heidelberg
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 14 of 40 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands